Under construction – not a live service

Skip to content

Frontlight Research

Trial site

AOU Policlinico di Palermo

Palermo, PA, ItalyNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Triple-negative breast cancer

Closed trials

Completed
Adjuvant Treatment for High-risk Triple Negative Breast Cancer Patients With the Anti-PD-l1 Antibody Avelumab
NCT02926196· Phase 3· Istituto Oncologico Veneto IRCCS· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – AOU Policlinico di Palermo: trial site – Frontlight Research